HealthDay News — The U.S. Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical trials. The move could soon mean more options for patients ...
Chris Spear and the ATA welcome an FDA rule change that targets drug test "cheating" by implementing oral fluid and hair ...
A swarm of tiny, shape-changing, all-metal robots might someday deliver drugs and capture biopsy samples painlessly and then ...
1hon MSN
College athletics leaders are begging for federal takeover. Another sport warns of ‘world of storms’
The sky is allegedly falling in college sports. Roster costs are skyrocketing, players are transferring far too much for the tastes of leadership, eligibility rules are under constant assault from ...
BetaKit spoke with three European participating founders in TBDC Horizon to understand why they chose to establish in Canada ...
Renato Canuto faces a hiccup in pursuit of crossover greatness. A Brazilian jiu-jitsu star who crossed into MMA in May 2025, ...
The US Food and Drug Administration (FDA) has issued warning letters to several firms that have violated current good ...
Roche’s Foundation Medicine has linked with Fulgent Genetics to offer a new diagnostic test that identifies a person’s ...
SHANGHAI, SHANGHAI, CHINA, April 30, 2026 /EINPresswire.com/ -- In today’s life sciences industry, moving a drug ...
Accelerated drug development expertise. For small startups and academic spinoffs bringing their first molecules to market, ...
The Food and Drug Administration (FDA) is set to pilot test real-time clinical trials in the hopes of expediting results and feedback, federal health officials announced on Tuesday.
The US Food and Drug Administration (FDA) recently issued three warning letters to facilities in China, the US, and India for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results